Sort
39,280 grants matching “leukemia”
ABL ONCOGENE AND MURINE AND HUMAN LEUKEMIAS
$420,051University Of California Los Angeles · R01 · FY2002 · CA
Pilot and definitive studies to evaluate Insertional Mutagenesis
$420,000Lu Taylor · Battelle Centers/Pub Hlth Res & Evaluatn · N01 · FY2013 · ES
Annexin 2 in Angiogenesis
$420,000Katherine Amberson Hajjar · Weill Medical Coll Of Cornell Univ · R01 · FY2008 · HL
Crosstalk between T cells and inflamed endothelium: regulation by Crk family proteins
$420,000Janis K. Burkhardt · Children'S Hosp Of Philadelphia · R01 · FY2018 · HL
Specialized post-transcriptional mechanisms of gene expression in quiescence
$420,000Shobha Vasudevan · Massachusetts General Hospital · R35 · FY2020 · GM
Crosstalk between T cells and inflamed endothelium: regulation by Crk family proteins
$420,000Janis K. Burkhardt · Children'S Hosp Of Philadelphia · R01 · FY2017 · HL
Crosstalk between T cells and inflamed endothelium: regulation by Crk family proteins
$420,000Janis K. Burkhardt · Children'S Hosp Of Philadelphia · R01 · FY2015 · HL
Specialized post-transcriptional mechanisms of gene expression in quiescence
$420,000Shobha Vasudevan · Massachusetts General Hospital · R35 · FY2021 · GM
Crosstalk between T cells and inflamed endothelium: regulation by Crk family proteins
$420,000Janis K. Burkhardt · Children'S Hosp Of Philadelphia · R01 · FY2016 · HL
Specialized post-transcriptional mechanisms of gene expression in quiescence
$420,000Shobha Vasudevan · Massachusetts General Hospital · R35 · FY2022 · GM
Mechanisms of resistance to WEE1 inhibition in Myc driven medulloblastoma
$419,996Rajeev Vibhakar · University Of Colorado Denver · R01 · FY2024 · NS
Project 1. Regulation of Mast Cell Homeostasis in Type 2 Immunopathology
$419,990Joshua A Boyce · Brigham And Women'S Hospital · U19 · FY2022 · AI
ADVANCED TECHNOLOGY FOR ASSAYING CANCER-DRUG RESISTANCE
$419,983Mark Lim · Ambergen, Inc · R44 · FY2010 · CA
LANGERHANS CELL REPLACEMENT FOLLOWING ALLOGENIC STEM CELL TRANSPLANTATION
$419,983Edgar G. Engleman · Stanford University · P01 · FY2008 · HL
ADVANCED TECHNOLOGY FOR ASSAYING CANCER-DRUG RESISTANCE
$419,983Mark Lim · Ambergen, Inc · R44 · FY2008 · CA
ADVANCED TECHNOLOGY FOR ASSAYING CANCER-DRUG RESISTANCE
$419,983Mark Lim · Ambergen, Inc · R44 · FY2009 · CA
MPN-inducing mutations as biomarkers of synthetic lethality
$419,768Tomasz Skorski · Temple Univ Of The Commonwealth · R01 · FY2023 · CA
MPN-inducing mutations as biomarkers of synthetic lethality
$419,768Tomasz Skorski · Temple Univ Of The Commonwealth · R01 · FY2022 · CA
CAR-T cell control through orthogonal antibody-based switches
$419,739Travis Scott Young · California Institute/Biomedical Research · R01 · FY2016 · CA
MECHANISMS OF LYMPHOID CANCER-RELATED CHEMONEUROPATHY
$419,730Patrick M Dougherty · University Of Tx Md Anderson Can Ctr · P01 · FY2012 · CA
STUDIES OF HERPES SIMPLEX VIRUS GLYCOPROTEINS
$419,609University Of Pennsylvania · R01 · FY2000 · AI
Project 4: Tumorigenic Effects of Tax
$419,534Lee Ratner · Ohio State University · P01 · FY2014 · CA
Microfluidic Point-of-care Cancer Cell Analyzer
$419,517Micronics, Inc. · R44 · FY2005 · CA
CHILDRENS CANCER GROUP
$419,517Children'S Hospital Of Philadelphia · U10 · FY2000 · CA
HIGH THROUGHPUT DETECTION OF GENETIC MUTATIONS AS BIOMARKERS OF FUT
$419,503Richard A Mathies · University Of California Berkeley · U54 · FY2010 · ES